FA
Insider selling
Frances Arnold sold $16K of Generate Biomedicines, Inc. (GENB) stock
Frances Arnold, Dir of Generate Biomedicines, Inc. (GENB), sold 1,000 shares of GENB stock worth $16K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 1, 2026, 2 days before it was made public.
GENB has moved +10.1% since the trade date, from $15.79 to $17.38 (Sep 21, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 2 days
- Price since
- +10.1%
- Role
- Dir
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.